Respiratory infections in immunocompromised patients

Area of Science:

• Immunology
• Infectious Diseases
• Public Health

Background:

• Highly active antiretroviral therapy (HAART) has significantly decreased HIV disease incidence in developed countries.
• Tuberculosis (TB) presents an increasing global health challenge for both HIV-infected and HIV-uninfected individuals.
• Directly observed therapy (DOT) is crucial for tuberculosis treatment adherence and control.

Purpose of the Study:

• To evaluate the role and implications of prophylactic therapy against opportunistic infections in the context of reduced HIV disease.
• To discuss the benefits and reservations of tuberculosis prophylaxis for tuberculin skin reactors with HIV, particularly in resource-limited settings.
• To highlight recent technological advancements in understanding HIV immunology and disease pathogenesis.

Main Methods:

• Review of current strategies for HIV disease management and tuberculosis control.
• Analysis of the impact of HAART on opportunistic infections.
• Exploration of technological advances, including antigen-specific systems and quantitative polymerase chain reaction (PCR).

Main Results:

• HAART has led to a dramatic reduction in HIV disease in developed regions.
• Tuberculosis continues to be a significant and escalating global health issue.
• Quantitative PCR is a valuable tool for predicting cytomegalovirus disease in transplant patients.
• CT scanning aids in diagnosing pulmonary aspergillosis in bone marrow transplant recipients.

Conclusions:

• While HAART has improved HIV outcomes, tuberculosis control remains paramount globally.
• Tuberculosis prophylaxis for HIV patients shows benefits in developed countries but requires careful consideration in resource-poor settings.
• Technological advancements are enhancing the understanding and management of HIV-related and other opportunistic infections.